Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Diseases chronic

Celiac Disease. A disturbance of the lower gastroiatestiaal tract, celiac disease is a chronic disease characterized by loss of appetite and weight, depression and irritabiUty, and diarrhea frequendy followed by constipation (35). One of the more disturbiag features of ceHac disease is the large, frothy, foul-smelling stools. The disease may develop ia childhood or later ia life. Frequendy, the patients who develop the disease ia adulthood report having had some of the symptoms duting childhood. [Pg.353]

National Research Council, Diet and Health Implicationsfor Reducing Chronic Disease Risk, National Academy Press, Washington, D.C., 1989. [Pg.137]

Fat Replacers. Eat has a ubiquitous presence in food and provides unique flavor, mouthfeel, and functional effects. At 9 kcal/g (38 kj/g), fat can be a principal source of dietary calories, and excessive consumption has been correlated with the incidence of chronic disease and morbidity. Health officials have strongly urged consumers to reduce fat intake to no more than 30% of daily calories. Therefore, a demand for low fat versions of high fat foods has developed. Eat replacers (qv) are the ingredients that make these foods possible. [Pg.439]

Galen, a physician whose views outUved him by about a thousand years, died about 200 AD. He beUeved that mercurials were toxic, and did not use any mercury compound therapeutically. However, as a result of Arabian influence, the therapeutic uses of mercury were slowly recognized by Western Europe. In the thirteenth century mercury ointments were prescribed for treating chronic diseases of the skin. Mercury and its compounds, such as mercurous chloride, mercuric oxide, mercuric chloride, and mercuric sulfide, were used widely from the fifteenth to the nineteenth centuries, and to some extent in the twentieth century. During the first half of the twentieth century, the primary therapeutic uses of mercury included bactericidal preparations, such as mercuric chloride, mercuric oxycyanide, and mercuric oxide and diuretics, such as aryl HgX (Novasural) and mercurated ahyl derivatives (14). [Pg.116]

Inovay, J. and Banoezy, J. The Role of Electrical Potential Differences in the Etiology of Chronic Diseases of the Oral Mucosa , Journal of Dental Research, 40, 884-890 (1961)... [Pg.467]

Epilepsy is a heterogeneous group of syndromes characterized by abnormal, rhythmic electrical activity of the brain or parts of the brain. The term epilepsy is reserved for chronic diseases, while a single, isolated seizure does not justify the diagnosis of epilepsy. [Pg.478]

The salicylates and nonsteroidal anti-inflammatory drug (NSAIDs) are important in the treatment of arthritic conditions. For example, the salicylates and NSAIDs are used in the treatment of rheumatoid arthritis (a chronic disease characterized by inflammatory changes within the body s connective tissue) and osteoarthritis (a noninflammatory joint disease resulting in degeneration of the articular cartilage and... [Pg.185]

Although the use of barbiturates and miscellaneous sedatives and hypnotics for sedation has largely been replaced by the antianxiety drugs (see Chap. 30), they occasionally may be used to provide sedation before certain types of procedures such as cardiac catheterization or the administration of a local or general anesthesia Sedative doses usually given during daytime hours, may be used to treat anxiety and apprehension. Fhtients with chronic disease may require sedation, not only to reduce anxiety, but also as an adjunct in the treatment of their disease... [Pg.240]

Older adults are at increased risk for adverse reactions from the antineoplastic drugs because of the increased incidence of chronic disease, particularly renal impairment or cardiovascular disease. When renal impairment is present, a lower dosage of the antineoplastic may be indicated. Creatinine clearance isused to monitor renal function in the older adult. Blood creatinine levels are likely to be inaccurate because of a decreased muscle mass in the older adult. [Pg.597]

Carroll KM, Ball SA, Nich C, et al Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence. Arch Gen Psychiatry 38 755-761, 2001 Centers for Disease Control and Prevention Recommendation for prevention and control of hepatitis (virus (HCV) infection and HCV-related chronic disease. MMWR Recommendations and Reports 47(RR19) l-39, 1998 Charney DS, Steinberg DE, Kleber HD, et al The clinical use of clonidine in abrupt withdrawal from methadone. Arch Gen Psychiatry 38 1273-1277, 1981 Charney D S, Heninger OR, Kleber H D The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone. Am J Psychiatry 143 831-837, 1986... [Pg.97]

Alcoholics Anonymous (AA) is a self-help organization for people whose common goal is recovery from alcoholism, and it is the most widely accessed resource for individuals with alcohol problems (McCrady and Miller 1993). The philosophy is based on the concept of alcoholism as a chronic disease that cannot be cured, but one that can be halted by means of complete abstinence. AA has described 12 principles or steps to guide those in recovery. Twelve-step facilitation, a manual-based psychotherapy to promote AA participation (Nowinski et al. 1992), was equally efficacious, compared with cognitive-behavioral and motivational enhancement therapies, in a large study of treatments for alcohol dependence (Project Match Research Group, 1997). [Pg.349]

Abstract This review provides an overview of the development of viral protease inhibitors as antiviral drugs. We concentrate on HlV-1 protease inhibitors, as these have made the most significant advances in the recent past. Thus, we discuss the biochemistry of HlV-1 protease, inhibitor development, clinical use of inhibitors, and evolution of resistance. Since many different viruses encode essential proteases, it is possible to envision the development of a potent protease inhibitor for other viruses if the processing site sequence and the catalytic mechanism are known. At this time, interest in developing inhibitors is Umited to viruses that cause chronic disease, viruses that have the potential to cause large-scale epidemics, or viruses that are sufQciently ubiquitous that treating an acute infection would be... [Pg.85]

Arnold R. Implementing automated chronic disease management support systems in asthma the promise and the pitfalls. Critical Issues in eHealth Research Conference. Bethesda, MD, 2005. [Pg.588]

Creatine phosphate is formed from ATP and creatine (Figure 49-16) at times when the muscle is relaxed and demands for ATP are not so great. The enzyme catalyzing the phosphorylation of creatine is creatine kinase (CK), a muscle-specific enzyme with clinical utility in the detection of acute or chronic diseases of muscle. [Pg.574]

There is now a growing body of evidence to suggest that phytochemicals may have a protective role against a variety of chronic diseases such as cancer and cardiovascular disease. Part 1 reviews this body of evidence, its strengths and its weaknesses. Chapter 2 discusses the ways in which phenolic... [Pg.1]

Many clinical studies have been performed on human subjects to assess the effect of soy isoflavones on chronic disease risk factors with no ill-effects (see Section 10.4). The safety profile of isoflavones is, however, difficult to establish because of the limited sample sizes and short periods of investigation of such studies. At present the upper tested limits are ... [Pg.208]

New research has demonstrated that carotenoids may also lend additional health benefits that may possibly reduce the risk of certain types of chronic diseases such as cancer and heart disease. Carotenoids are also important natural sources of orange, yellow, and red food coloring for the food and beverage industries. ... [Pg.51]

Fruifs and vegetables also contain ofher bioactive substances such as polyphenols (including well-known pigments anthocyanins, flavonols) and non-provitamin A carotenoids (mainly lycopene, lutein, and zeaxanthin) that may have protective effects on chronic diseases. Polyphenols and carotenoids are known to display antioxidant activities, counteracting oxidative alterations in cells. Besides these antioxidant properties, these colored bioactive substances may exert other actions on cell signaling and gene expression. [Pg.127]

The purpose of this chapter is to provide an overview of our present knowledge about the health benehts of pigments, particularly their effects on chronic diseases. We examine the effects of lipophilic (carotenoids, chlorophylls) and hydrophilic pigments (anthocyanins and flavones-flavonols), and curcumin. Descriptive and mechanistic studies are reviewed in regard to common chronic diseases. [Pg.128]

The protective effects of carotenoids against chronic diseases appear to be correlated to their antioxidant capacities. Indeed, oxidative stress and reactive oxygen species (ROS) formation are at the basis of oxidative processes occurring in cardiovascular incidents, cancers, and ocular diseases. Carotenoids are then able to scavenge free radicals such as singlet molecular oxygen ( O2) and peroxyl radicals particularly, and protect cellular systems from oxidation. [Pg.135]


See other pages where Diseases chronic is mentioned: [Pg.386]    [Pg.431]    [Pg.374]    [Pg.7]    [Pg.7]    [Pg.7]    [Pg.400]    [Pg.131]    [Pg.133]    [Pg.332]    [Pg.325]    [Pg.145]    [Pg.539]    [Pg.581]    [Pg.928]    [Pg.1150]    [Pg.1294]    [Pg.432]    [Pg.9]    [Pg.99]    [Pg.268]    [Pg.479]    [Pg.51]    [Pg.123]    [Pg.210]    [Pg.254]    [Pg.258]    [Pg.288]    [Pg.347]    [Pg.353]   
See also in sourсe #XX -- [ Pg.133 , Pg.136 , Pg.177 ]

See also in sourсe #XX -- [ Pg.858 , Pg.859 , Pg.860 , Pg.861 , Pg.862 , Pg.863 , Pg.864 , Pg.865 , Pg.866 , Pg.867 , Pg.868 , Pg.869 , Pg.870 , Pg.871 , Pg.872 , Pg.873 ]

See also in sourсe #XX -- [ Pg.858 , Pg.859 , Pg.860 , Pg.861 , Pg.862 , Pg.863 , Pg.864 , Pg.865 , Pg.866 , Pg.867 , Pg.868 , Pg.869 , Pg.870 , Pg.871 , Pg.872 , Pg.873 ]

See also in sourсe #XX -- [ Pg.396 , Pg.416 , Pg.984 , Pg.1180 ]




SEARCH



A Systems Biology Approach to Target Identification and Validation for Human Chronic Disease Drug Discovery

Adrenal insufficiency chronic disease

Agents for Chronic Obstructive Pulmonary Disease (COPD)

Aging chronic diseases, free radical

Alcohol chronic liver disease

Anemia in chronic kidney disease

Anemia of chronic disease

Anemia of chronic kidney disease

Animal models of chronic lung disease

Beryllium chronic pulmonary disease

Biliary atresia chronic liver disease

Blood chronic liver diseases

Bronchitis, chronic pulmonary disease

C and Chronic Diseases

Carotenoid, chronic disease

Chemokine chronic pulmonary disease with

Children chronic liver disease

Chronic Obstructive Pulmonary Disease

Chronic alcoholic liver disease

Chronic beryllium disease

Chronic beryllium disease treatment

Chronic cardiovascular disease

Chronic conditions, disease groups

Chronic conditions, disease groups based

Chronic disease and cancer chemotherapy

Chronic disease anemia

Chronic disease clinical presentation

Chronic disease complications

Chronic disease definition

Chronic disease management

Chronic disease pathophysiology

Chronic disease pharmacologic therapy

Chronic disease progression

Chronic disease stages

Chronic disease, oral drug absorption

Chronic disease, treatment

Chronic diseases leukemia

Chronic diseases myeloproliferative disorders

Chronic diseases obstructive pulmonary disease

Chronic diseases plant-based diets

Chronic diseases resveratrol

Chronic diseases treatment principles

Chronic granulomatous disease

Chronic granulomatous disease NADPH-oxidase

Chronic granulomatous disease of childhood

Chronic granulomatous disease treatment

Chronic heart diseases

Chronic infectious disease

Chronic inflammatory diseases

Chronic inflammatory diseases neutrophils

Chronic ischemic heart disease

Chronic ischemic heart disease acute coronary syndromes

Chronic ischemic heart disease exercise

Chronic ischemic heart disease, effects

Chronic kidney disease

Chronic kidney disease aminoglycosides

Chronic kidney disease and

Chronic kidney disease drug dosing

Chronic kidney disease hyperphosphatemia

Chronic kidney disease hypocalcemia

Chronic kidney disease smoking

Chronic kidney disease tubular proteinuria

Chronic neurodegenerative disease

Chronic neuroinflammatory diseases

Chronic obstructive disease

Chronic obstructive lung disease

Chronic obstructive lung disease pathogenesis

Chronic obstructive pulmonary disease 2-agonists

Chronic obstructive pulmonary disease COPD exacerbations

Chronic obstructive pulmonary disease COPD)

Chronic obstructive pulmonary disease NIPPV

Chronic obstructive pulmonary disease acute exacerbation

Chronic obstructive pulmonary disease administration routes

Chronic obstructive pulmonary disease airflow limitation

Chronic obstructive pulmonary disease airflow obstruction

Chronic obstructive pulmonary disease airway obstruction

Chronic obstructive pulmonary disease anti-inflammatories

Chronic obstructive pulmonary disease antibiotics

Chronic obstructive pulmonary disease anticholinergics

Chronic obstructive pulmonary disease arrhythmia

Chronic obstructive pulmonary disease asthma

Chronic obstructive pulmonary disease bronchodilators

Chronic obstructive pulmonary disease budesonide

Chronic obstructive pulmonary disease case study

Chronic obstructive pulmonary disease classification

Chronic obstructive pulmonary disease clinical presentation

Chronic obstructive pulmonary disease combination therapy

Chronic obstructive pulmonary disease corticosteroids

Chronic obstructive pulmonary disease cystic fibrosis

Chronic obstructive pulmonary disease definition

Chronic obstructive pulmonary disease diagnosis

Chronic obstructive pulmonary disease drug development

Chronic obstructive pulmonary disease drug therapy

Chronic obstructive pulmonary disease epidemiology

Chronic obstructive pulmonary disease etiology

Chronic obstructive pulmonary disease evaluation

Chronic obstructive pulmonary disease exacerbation

Chronic obstructive pulmonary disease expectorants

Chronic obstructive pulmonary disease glucocorticoids

Chronic obstructive pulmonary disease immunizations

Chronic obstructive pulmonary disease inflammation

Chronic obstructive pulmonary disease lung transplantation

Chronic obstructive pulmonary disease methylxanthines

Chronic obstructive pulmonary disease monitoring

Chronic obstructive pulmonary disease mortality from

Chronic obstructive pulmonary disease mucolytics

Chronic obstructive pulmonary disease noninvasive positive-pressure ventilation

Chronic obstructive pulmonary disease oxygen therapy

Chronic obstructive pulmonary disease pathophysiology

Chronic obstructive pulmonary disease patients with severe

Chronic obstructive pulmonary disease pneumonia

Chronic obstructive pulmonary disease prognosis

Chronic obstructive pulmonary disease randomized controlled trials

Chronic obstructive pulmonary disease respiratory acidosis with

Chronic obstructive pulmonary disease respiratory failure

Chronic obstructive pulmonary disease respiratory stimulants

Chronic obstructive pulmonary disease risk factors

Chronic obstructive pulmonary disease severity

Chronic obstructive pulmonary disease smoking cessation

Chronic obstructive pulmonary disease specific agents

Chronic obstructive pulmonary disease theophylline

Chronic obstructive pulmonary disease tiotropium bromide

Chronic obstructive pulmonary disease tobacco smoke

Chronic obstructive pulmonary disease treatment

Chronic obstructive pulmonary disease vaccination

Chronic painful inflammatory disease

Chronic pulmonary disease

Chronic renal disease

Chronic viral diseases

Chronic wasting disease

Chronic wasting disease strains

Chronic wasting disease transmission

Cirrhosis chronic liver disease

Common symptoms shared by chronic diseases

Coronary artery disease chronic occlusions

Deer, chronic-wasting disease

Dietary supplements chronic diseases

Diseases/disorders, chronic

Fat and Obesity-Related Chronic Disease

Fluid balance in chronic kidney disease

Foods and Obesity-Related Chronic Disease

Free radicals involvement in chronic diseases and

Gastrointestinal disease chronic pancreatitis

Glomerular filtration rate in chronic kidney disease

Graft-versus-host disease chronic

HbsAg-positive chronic liver disease

Heart failure chronic obstructive pulmonary disease

Hepatic disease chronic hepatitis

Hepatitis chronic disease

Hepatitis chronic liver disease

Hyperkalemia in chronic kidney disease

Hyperphosphatemia in chronic kidney disease

In chronic obstructive pulmonary disease

Ipratropium chronic obstructive pulmonary disease

Ischaemic heart disease chronic

Kidney disease, chronic biopsy

Kidney disease, chronic classification

Kidney disease, chronic clinical presentation

Kidney disease, chronic complications

Kidney disease, chronic definition

Kidney disease, chronic diuretics

Kidney disease, chronic electrolytes

Kidney disease, chronic epidemiology

Kidney disease, chronic erythropoietin

Kidney disease, chronic etiology

Kidney disease, chronic evaluation

Kidney disease, chronic glomerular filtration rate

Kidney disease, chronic goals

Kidney disease, chronic hemodialysis

Kidney disease, chronic hyperkalemia

Kidney disease, chronic hyperparathyroidism

Kidney disease, chronic infectious diseases

Kidney disease, chronic initiation factors

Kidney disease, chronic iron therapy

Kidney disease, chronic malnutrition

Kidney disease, chronic metabolic acidosis

Kidney disease, chronic microalbuminuria

Kidney disease, chronic pathophysiology

Kidney disease, chronic peritoneal dialysis

Kidney disease, chronic progression

Kidney disease, chronic progression factors

Kidney disease, chronic progression-modifying therapies

Kidney disease, chronic protein metabolism

Kidney disease, chronic renal osteodystrophy

Kidney disease, chronic renal replacement therapy

Kidney disease, chronic serum creatinine

Kidney disease, chronic stage

Kidney disease, chronic staging

Kidney disease, chronic susceptibility factors

Kidney disease, chronic treatment

Liver chronic disease, plasma protein

Liver disease chronic

Lungs chronic disease

Malnutrition and Chronic Diseases

Obesity-related chronic disease

Obesity-related chronic disease 2 diabetes

Obesity-related chronic disease cardiovascular diseases

Occupational illnesses chronic diseases

Periodontal disease chronic periodontitis

Portal hypertension chronic liver disease

Prevention of chronic diseases

Renal disease chronic parenchymal

Respiratory diseases bronchitis, chronic

Respiratory disorders chronic obstructive pulmonary disease

Salbutamol chronic obstructive pulmonary disease

Scarring, chronic diseases

Sickle cell anemia/disease chronic

Smoking chronic obstructive pulmonary disease

Tubulointerstitial disease chronic interstitial nephritis

Uremia Chronic renal disease

Vitamin chronic disease prevention

Wilson disease chronic hepatitis

© 2024 chempedia.info